Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_assertion description "[A2M, LRP1 (encoding the alpha-2M receptor) and the genes for two other LRP ligands, APOE and APP (encoding the amyloid beta-protein precursor), have now all been genetically linked to AD, suggesting that these proteins may participate in a common neuropathogenic pathway leading to AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_assertion evidence source_evidence_literature NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_assertion SIO_000772 9697696 NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_assertion wasDerivedFrom befree-20150227 NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_assertion wasGeneratedBy ECO_0000203 NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.
- befree-20150227 importedOn "2015-02-27" NP843524.RAPEVn9QBKw6hLThICzR6vkxkKxAIoHiuXTgI9VhfZNek130_provenance.